2016 American Transplant Congress

Tuesday, June 14, 2016

6:00pm-7:00pm

Results of a Biopsy Based, Early Intervention Treatment Protocols for BK Viraemia and BK Virus Associated Nephropathy.

S. Jones,¹ S. Waller,¹ K. Lai,^2,3 A. Hibbard,¹ P. Trevillian,¹ M. Heer.¹

Poster Session D: Polyomavirus  •  Halls C&D

6:00pm-7:00pm

Resveratrol Attenuates Liver IRI by Regulating Macrophage Activation Through SIRT1/p19/p53 Pathway.

K. Nakamura,¹ M. Zhang,² B. Ke,¹ S. Kageyama,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D

6:00pm-7:00pm

Risk Factors for Clinical Urinary Tract Infections in Kidney Transplant Recipients with Asymptomatic Bacteriuria.

S. Medani, M. Dorais, A. Tavares-Brum, H. Mawad, A. Duclos, C. Lemieux, A. Barama, H. Cardinal.

Poster Session D: Fungi, PJP, Mycobacteria, Infection Risk Factors, Vaccination and Donor Derived Infections  •  Halls C&D

6:00pm-7:00pm

Risk Factors for Early vs. Late Onset Clostridium difficile Infection(CDI) in Solid Organ Transplant Recipients (SOTR).

Y. Natori, M. Shiotsuka, L. Oen, E. Renner, L. Singer, H. Ross, D. Kumar, C. Rotstein, A. Humar, S. Husain.

Poster Session D: Fungi, PJP, Mycobacteria, Infection Risk Factors, Vaccination and Donor Derived Infections  •  Halls C&D

6:00pm-7:00pm

Risk Factors for Single and Recurrent Symptomatic Urinary Tract Infections within the First Year After Kidney Transplantation.

K. Bourgi, W. Choi, A. Nakhle, Z. Abdel-Rahman, O. Abreu-Lanfranco, M. Ramesh, A. Patel, R. Del Busto, G. Alangaden.

Poster Session D: Poster Session II: Kidney Complications-Other  •  Halls C&D

6:00pm-7:00pm

Risk of Peritoneal Dialysis Catheter-Associated Peritonitis Following Kidney Transplant.

A. Rizzi,¹ S. Ruitta,¹ J. Peterson,¹ G. Gagin,¹ D. Fritze,¹ R. Sung,¹ Y. Lu,² K. Woodside.¹

Poster Session D: Poster Session II: Kidney Complications-Other  •  Halls C&D

6:00pm-7:00pm

Role of Preformed IgM Donor Human Leucocyte Antigen (HLA) Specific Antibodies in HLA Incompatible Renal Transplantation.

A. Andreou, A. Babu, T. Barber, R. Higgins, D. Briggs, D. Mitchell, N. Khovanova, T. Shaikhina, S. Daga.

Poster Session D: Antibody Mediated Rejection: Session #2  •  Halls C&D

6:00pm-7:00pm

Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.

K. Gutierrez, J. Scheuermann, I. Goldvarg, S. Joshi, G. Tyson, N. Bzowej, N. Girgrah, S. Anders, G. Loss, G. Therapondos.

Poster Session D: Viral Hepatitis  •  Halls C&D

6:00pm-7:00pm

Schisandra Sphenanthera Extract Facilitates Anti-Tuberculosis Treatment Post Renal Transplantation Through Increasing Bioavailability of Tacrolimus.

R. Deng,¹ L. Zhang,¹ L. Liu,¹ H. Fu,² J. Li,¹ Q. Fu,¹ C. Wang.¹

Poster Session D: Kidney Immunosuppression: Novel Agents  •  Halls C&D

6:00pm-7:00pm

Shifts of Etiology in Patients with in Bacteremic Liver Transplant Recipients.

S. Kim,¹ Y. Kim,¹ J. Choi,¹ S. Yoon,¹ G. Na,² J. Kim,² I. Moon,² Y. Yoo,² D. Kim.²

Poster Session D: Fungi, PJP, Mycobacteria, Infection Risk Factors, Vaccination and Donor Derived Infections  •  Halls C&D